BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23447589)

  • 1. Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis.
    Melnikova T; Fromholt S; Kim H; Lee D; Xu G; Price A; Moore BD; Golde TE; Felsenstein KM; Savonenko A; Borchelt DR
    J Neurosci; 2013 Feb; 33(9):3765-79. PubMed ID: 23447589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
    Oulès B; Del Prete D; Greco B; Zhang X; Lauritzen I; Sevalle J; Moreno S; Paterlini-Bréchot P; Trebak M; Checler F; Benfenati F; Chami M
    J Neurosci; 2012 Aug; 32(34):11820-34. PubMed ID: 22915123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-related dimorphism in dentate gyrus atrophy and behavioral phenotypes in an inducible tTa:APPsi transgenic model of Alzheimer's disease.
    Melnikova T; Park D; Becker L; Lee D; Cho E; Sayyida N; Tian J; Bandeen-Roche K; Borchelt DR; Savonenko AV
    Neurobiol Dis; 2016 Dec; 96():171-185. PubMed ID: 27569580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
    Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
    Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis.
    Xu G; Fromholt SE; Chakrabarty P; Zhu F; Liu X; Pace MC; Koh J; Golde TE; Levites Y; Lewis J; Borchelt DR
    Acta Neuropathol Commun; 2020 Apr; 8(1):43. PubMed ID: 32252825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
    Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
    J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
    Mitani Y; Yarimizu J; Akashiba H; Shitaka Y; Ni K; Matsuoka N
    J Neurochem; 2013 May; 125(3):465-72. PubMed ID: 23240999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
    Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
    J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
    Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
    J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice.
    Saura CA; Chen G; Malkani S; Choi SY; Takahashi RH; Zhang D; Gouras GK; Kirkwood A; Morris RG; Shen J
    J Neurosci; 2005 Jul; 25(29):6755-64. PubMed ID: 16033885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.
    Gandy S; Simon AJ; Steele JW; Lublin AL; Lah JJ; Walker LC; Levey AI; Krafft GA; Levy E; Checler F; Glabe C; Bilker WB; Abel T; Schmeidler J; Ehrlich ME
    Ann Neurol; 2010 Aug; 68(2):220-30. PubMed ID: 20641005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain oligomeric β-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein/tau transgenic mice.
    DaRocha-Souto B; Scotton TC; Coma M; Serrano-Pozo A; Hashimoto T; Serenó L; Rodríguez M; Sánchez B; Hyman BT; Gómez-Isla T
    J Neuropathol Exp Neurol; 2011 May; 70(5):360-76. PubMed ID: 21487307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
    Wu M; Shi H; He Y; Yuan L; Qu X; Zhang J; Wang Z; Cai H; Qi J
    J Alzheimers Dis; 2017; 59(3):1067-1078. PubMed ID: 28731445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice.
    Hoshino T; Murao N; Namba T; Takehara M; Adachi H; Katsuno M; Sobue G; Matsushima T; Suzuki T; Mizushima T
    J Neurosci; 2011 Apr; 31(14):5225-34. PubMed ID: 21471357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
    J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.